Naltrexone: An Effective Cancer Therapy

Low dose naltrexone (LDN) is effective in supporting the immune system for those with HIV, and cancer by raising the endorphin and enkephalin levels created by this drug impacts the tumors’ opioid receptors and induce the death of cancerous cells. It is also suggested that LDN works like a natural painkiller and improve the body’s defense mechanisms against cancer.